WebHelp us improve CareerBuilder by providing feedback about this job: Report this job Job ID: 2481479565. CareerBuilder TIP. For your privacy and protection, when applying to a job … Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ). Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and c…
Shionogi Inc Careers and Employment Overview Indeed.com
Web1 day ago · Shionogi Inc. Associate Director, Scientific Communications Florham Park, NJ Today $95K-$137K Per Year (Glassdoor est.) Shionogi Inc. Director, Compliance Florham Park, NJ 12d $103K-$154K Per Year (Glassdoor est.) Shionogi Inc. Principal Data Manager Florham Park, NJ 30d+ Shionogi Inc. Key Account Manager United States 2d Shionogi Inc. WebMar 15, 2024 · Cons. Only concerned with How many calls you make a day. Management prefers to be lied to about call metrix and everyday field activity. They have a False sense on what the real day to day activities are. This company has had a lot of turnover, with Layoffs, people resigning. The leadership is terrible. Company has really 1 product, the way ... avan y evan
GSK ANNOUNCES SETTLEMENT BETWEEN - ViiV Healthcare
WebFounded 2010 Company size 201 to 500 Revenue $100M to $500M (USD) Industry Pharmaceutical & Biotechnology Headquarters Florham Park, NJ Shionogi Inc website Learn more Jobs We were not able to detect your location. You can browse through all 23 jobs Shionogi Inc has to offer Full-time HR Receptionist & Office Coordinator Florham Park, NJ WebFetroja®(cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacaecomplex. WebApr 13, 2024 · Shionogi & Co., Ltd. Announces Initiation of a Global Late Phase 2 Clinical Trial of Investigational Redasemtide in Patients with Acute Ischemic Stroke avan uerj